MAPT and Parkinson disease: In early clinical PD, levels of t-tau and p-tau in CSF are lower than in control patients and are highly correlated with CSF measurements of total-alpha-synuclein [104], further suggesting that the accumulation of tau pathology and pathogenic species released into CSF may be distinct in LBD compared to AD and normal aging.